The role of postradiotherapy neck dissection in supraglottic carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 50, Issue 2, 2001, Pages 367-375

  Chan, Annie W ^a   Ancukiewicz, Marek ^a   Carballo, Natalia ^a   Montgomery, William ^b   Wang, C C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b

^c United States

Author keywords

Accelerated hyperfractionation; Neck dissection; Radiotherapy; Regional response; Supraglottic carcinoma

Indexed keywords

CELLS; DISEASES; FRACTIONATION; RADIOTHERAPY;

POSTRADIOTHERAPY NECK DISSECTION;

ONCOLOGY;

ADULT; AGED; ARTICLE; CANCER STAGING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; RISK FACTOR; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY; SEX FACTORS;

EID: 0035371497     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01468-7     Document Type: Article

References (26)

1. Cooper J.S., Farnan N.C., Asbell S.O., et al. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer. 77:1996;1905-1911.
2. Cerezo L., Millan I., Torre A., et al. Prognostic factors for survival and tumor control in cervical lymph node metastasis from head and neck cancer. Cancer. 69:1992;1224-1234.
3. Boyd T.S., Harari P.M., Tannehill S.P., et al. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer. Head Neck. 20:(2):1998;132-137.
4. Lee H.J., Zelefsky M.J., Kraus D.H., et al. Long-term regional control after radiation therapy and neck dissection for base of tongue carcinoma. Int J Radiat Oncol Biol Phy. 38:(5):1997;995-1000.
5. Parsons J.T., Mendenhall W.M., Cassisi N.J., et al. Neck dissection after twice-a-day radiotherapy Morbidity and relapse rates . Head Neck Surg. 11:1989;400-404.
6. Mendenhall W.M., Million R.R., Cassisi N.J. Squamous cell carcinoma of the head and neck treated with radiation therapy The role of neck dissection for clinically positive neck nodes . Int J Radiat Oncol Biol Phy. 12:1986;733-740.
7. Mendenhall W.M., Amdur R.J., Stringer S.P., et al. Radiation therapy for squamous cell carcinoma of the tonsillar region A preferred alternative to surgery? J Clin Oncol. 18:2000;2219-2225.
8. Mendenhall W.M., Stringer S.P., Amdur R.J., et al. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue? J Clin Oncol. 18:2000;35.
9. Johnson C.R., Silverman L.N., Clay L.B., et al. Radiotherapeutic management of bulky cervical lymphadenopathy in squamous cell carcinoma of the head and neck Is postradiotherapy neck dissection necessary? Radiat Oncol Investig. 6:(1):1998;52-57.
10. Peters L.J., Weber R.S., Morrison W.H., et al. Neck surgery in patients with primary oropharyngeal cancer treated by radiotherapy. Head Neck. 18:(6):1996;552-5599.
11. Mabanta S.R., Mendenhall W.M., Stringer S.P., et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head & Neck. 21:(7):1999;591-594.
12. Bataini J.P., Bernier J., Jaulerry C., et al. Impact of neck node radioresponsiveness on the regional control probability in patients with oropharynx and pharyngolarynx cancers managed by definitive radiotherapy. Int J Radiat Oncol Biol Phys. 13:1987;817-824.
13. Bernier J., Bataini J.P. Regional outcome in oropharyngeal and laryngopharyngeal cancer treated with high dose per fraction radiotherapy Analysis of neck disease response in 1646 cases . Radiother Oncol. 6:1986;87-103.
14. Bartelink H., Breur K., Hart G. Radiotherapy of lymph node metastasis in patients with squamous cell carcinoma of the head and neck region. Int J Radiat Oncol Biol Phys. 8:1982;983-989.
15. Narayan K., Crane C.H., Kleid S., et al. Planned neck dissection as an adjunct to the management of patients with advanced neck disease treated with definitive radiotherapy For some or for all? Head Neck. 21:1999;606-613.
16. American Joint Committee on Cancer. Manual for staging of cancer, 5th ed. Philadelphia, PA: Lippincott Co; 1997. p. 41-46.
17. Nakfoor B.M., Spiro I.J., Wang C.C., et al. Results of accelerated radiotherapy for supraglottic carcinoma A Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary Experience . Head Neck. 20:1998;379-384.
18. Wang C.C., Suit H.D., Blitzer P.H. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phy. 12:1985;3-7.
19. Wang C.C., Nakfoor B.M., Spiro I.R., et al. Role of accelerated fractionated irradiation for supraglottic carcinoma Assessment of results . Cancer J Sci Am. 3:1997;88-91.
20. Wang CC. Radiation therapy for head and neck neoplasm. 3rd ed. New York, NY: Wiley-Liss Co; 1997. p. 240-249.
21. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the radiation the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
22. Overgaard J., Hansen H.S., Jorgensen K., et al. Primary radiotherapy of larynx and pharynx carcinoma - An analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys. 12:1986;515-521.
23. Overgaard J., Hansen H.S., Overgaard M., et al. A randomized double-blind Phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol. 46:(2):1998;135-146.
24. Carl J., Andersen L.J., Pedersen M., et al. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx. Radiother Oncol. 39:(3):1996;229-233.
25. Maciejewski B. Regression rate of metastatic neck lymph nodes after radiation treatment as a prognostic factor for local control. Radiother Oncol. 8:1987;301-308.
26. Suit H., Lindberg R., Fletcher G.H. Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology. 84:1965;1100-1107.